Understanding liver cancer risk in Hispanics with cirrhosis

Multilevel factors associated with heterogeneity in risk of liver cancer within Hispanics with cirrhosis

NIH-funded research Baylor College of Medicine · NIH-11080090

This study is looking at what might increase or decrease the chances of getting liver cancer in Hispanic people who have cirrhosis, and it aims to find ways to help with early detection and prevention.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11080090 on NIH RePORTER

What this research studies

This research investigates the various factors that contribute to the risk of liver cancer, specifically focusing on Hispanic individuals with cirrhosis. By analyzing a large cohort of patients, the study aims to identify both risk and protective factors related to metabolic liver disease. The approach includes measuring metabolic traits and biomarkers, as well as exploring strategies for prevention and early diagnosis of liver cancer. Patients may be involved in assessments that could lead to improved surveillance and treatment options.

Who could benefit from this research

Good fit: Ideal candidates for this research are Hispanic individuals diagnosed with cirrhosis, particularly those affected by metabolic liver disease.

Not a fit: Patients without cirrhosis or those from non-Hispanic backgrounds may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and treatment strategies for liver cancer in Hispanic populations.

How similar studies have performed: Previous research has shown promising results in understanding liver cancer risk factors in diverse populations, making this approach both relevant and potentially impactful.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer CauseCancer EtiologyDiabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.